IREN Ltd Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IREN Limited on October 14, 2025. The filing reports the closing of a significant capital raise involving the issuance of convertible senior notes and the execution of related hedging transactions.
Key Financial Metrics and Transaction Details
- Debt Issuance: Issued $1.125 billion aggregate principal amount of 0.00% Convertible Senior Notes due 2031 (including $125 million from the full exercise of an over-allotment option).
- Net Proceeds: Approximately $979.0 million after deducting discounts, commissions, and estimated offering expenses.
- Use of Proceeds: $56.7 million used to fund capped call transactions; the remainder designated for general corporate purposes and working capital.
- Interest Rate: 0.00% (no regular interest payments).
- Maturity Date: July 1, 2031.
- Conversion Terms: Initial conversion rate of 11.6784 ordinary shares per $1,000 principal amount (initial conversion price of approximately $85.63 per share).
- Maximum Dilution: Up to 16,641,700 ordinary shares may be issued upon conversion based on the initial maximum conversion rate.
Material Changes and Hedging Strategy
The Company entered into privately negotiated capped call transactions with Citibank, N.A., Banco Santander, S.A., Mizuho Markets Americas LLC, and Wells Fargo Bank, National Association. These transactions cover the shares underlying the Convertible Notes and are designed to reduce potential dilution or offset cash payments upon conversion.
- Cap Price: Initially set at $120.18 per share (a 100% premium over the $60.09 share price on October 8, 2025).
- Cost: $56.7 million, funded from the net proceeds of the note offering.
- Settlement: Transactions are solely cash settled unless specific conditions are met.
Outlook, Risks, and Management Commentary
Management intends to use the remaining net proceeds for general corporate purposes and working capital. The filing includes standard forward-looking statements regarding business plans and strategies, noting that actual results may differ materially due to risks and uncertainties.
Key Risks and Provisions:
- Redemption: The Company may redeem the notes on or after January 8, 2029, if the share price exceeds 130% of the conversion price for a specified period.
- Fundamental Change: Noteholders may require the Company to repurchase the notes at par plus accrued interest if certain fundamental changes (e.g., business combinations, delisting) occur.
- Events of Default: Includes payment defaults, failure to comply with covenants, and bankruptcy events. Certain reporting covenant failures may result in special interest penalties rather than immediate acceleration.
Investor Verification Checklist
- Verify the final settlement of the $979.0 million net proceeds and confirm the allocation to working capital versus the capped call cost.
- Monitor the Company's share price relative to the $85.63 conversion price and the $120.18 cap price to assess dilution risk and hedging effectiveness.
- Review the full Indenture (Exhibit 4.1) for specific covenants regarding asset sales, mergers, and subsidiary indebtedness.
- Confirm the status of the over-allotment option exercise and the total outstanding principal of $1.125 billion.
- Assess the impact of the 0.00% interest rate on the Company's future cash flow requirements compared to traditional debt instruments.